This is not the most recent version of the article. View current version (13 NOV 2014)

Intervention Protocol

Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer

  1. Gianpaolo Perletti1,*,
  2. Vittorio Magri2,
  3. Emanuela Marras3,
  4. Elena Monti4,
  5. Paul S Rennie5,
  6. Alberto Trinchieri6

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 15 AUG 2012

DOI: 10.1002/14651858.CD009998


How to Cite

Perletti G, Magri V, Marras E, Monti E, Rennie PS, Trinchieri A. Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD009998. DOI: 10.1002/14651858.CD009998.

Author Information

  1. 1

    Università degli Studi dell'Insubria, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Dept. of Theoretical and Applied Sciences, Busto A, Province of Varese, Italy

  2. 2

    Istituti Clinici di Perfezionamento, Urology/Urological Sonography Secondary Care Clinic, Milano, Italy

  3. 3

    Dept. of Theoretical and Applied Sciences, Università degli Studi dell'Insubria, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Busto A, Lombardy, Italy

  4. 4

    University of Insubria, Biomedical Research Division, Department of Theoretical and Applied Sciences, Varese, Italy

  5. 5

    University of British Columbia, Vancouver Prostate Centre, Vancouver, British Columbia, Canada

  6. 6

    A. Manzoni Hospital, Urology Unit, Lecco, Italy

*Gianpaolo Perletti, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Dept. of Theoretical and Applied Sciences, Università degli Studi dell'Insubria, Via A. da Giussano, 10, Busto A, Province of Varese, 21052, Italy. gianpaolo.perletti@uninsubria.it.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012

SEARCH